GHRP-6 vs Hexarelin: which secretagogue published binding studies actually pick, and why
8 min read · Research use only
Written and reviewed by BluGen Research Team · Editorial standards
Two hexapeptides, same receptor, almost the same molecular weight, and a measurable affinity gap that drives which one published binding studies actually pick. The choice is not arbitrary.
Identity at a glance
GHRP-6 is a 6-residue ghrelin-receptor (GHS-R1a) agonist, MW ≈ 873 Da. Hexarelin is a 6-residue methylated GHRP-6 analogue, MW ≈ 887 Da. The methylation is the structural feature responsible for higher reported binding affinity at the same receptor.
Treat each SKU as a separate line on the CoA review even when they ship in the same procurement cycle. Sequence, modification and molecular weight are the fields that decide whether your protocol is reproducible.
Mechanism and research framing
Both engage GHS-R1a / Gq / IP3 signalling. Reported binding affinities in published research place Hexarelin tighter at the receptor than GHRP-6 by a small but reproducible margin. For comparative selectivity work, this is often the deciding factor.
Cite the literature each reference actually lives in, rather than transferring assumptions from the adjacent material. Matched buffers, matched controls and matched concentration ranges are the floor for comparative work.
Storage, stability and lab handling
Storage handling is similar: lyophilised, cold, dry, light-protected. Reconstituted Hexarelin solutions tend to be marginally more stable in matched buffers, but the bigger driver in lab-to-lab variability is aliquot management, not the peptide difference.
Aliquot before first freeze, label with lot and reconstitution date, and document freeze-thaw count per vial. Stability assumptions do not transfer between adjacent references even when the storage temperature does.
Next steps for procurement and the lab bench
If you are stocking Ghrp 6 and Hexarelin for parallel work, build the CoA package, the storage SOP and the reconstitution log before the order ships rather than after.
Pair this comparison with each product page, the matching product research guide, the storage guide and the CoA review guide. The internal links below route directly into those resources.
Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.
When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.
Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.
If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.
Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.
Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.
When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.
Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.
If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.
Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.
Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.
When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.
Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.
If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.
Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.
Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.
When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.
Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.
If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.
Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.
Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.
When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.
Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.
If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.
Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.
Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.
When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.
Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.
If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.
Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.
Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.
When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.
Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.
If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.
Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.
Document reviewers should cross-link this guide with the product certificate of analysis and internal receiving SOP.
When publishing methods, cite lot number, SKU, reconstitution buffer, and stock concentration so external labs can interpret your figures.
Institutional procurement may require RUO acknowledgment at checkout; store that acknowledgment beside batch records for audits.
If assay results drift across quarters, compare storage logs and CoA revision before questioning sequence integrity.
Third-party summaries, when available, should be filed as supplements—not replacements—for CoA identity data.
Frequently asked questions
Why do some published assays prefer Hexarelin?
Reported binding affinity at GHS-R1a is higher than GHRP-6 in matched receptor-binding studies. For selectivity-focused work, this is usually why Hexarelin is chosen.
Is GHRP-6 "outdated" relative to Hexarelin?
No. GHRP-6 has a deeper published literature base. Hexarelin is preferred where binding-affinity precision matters; GHRP-6 remains the standard secretagogue reference in many research programs.
Should I treat Ghrp 6 and Hexarelin as interchangeable in my study?
No. Even adjacent research references differ in receptor, sequence, modification, or stability. Review each CoA, storage SOP and protocol independently before substituting.
What is the highest-value field to compare first?
Sequence and receptor target. Molecular weight and HPLC purity validate the SKU, but receptor identity decides whether the materials are research-equivalent at all.
Citation
BluGen Research Peptides — GHRP-6 vs Hexarelin: which secretagogue published binding studies actually pick, and why. https://getblugen.com/research/ghrp-6-vs-hexarelin-secretagogue-research-comparison/. Accessed 2026-06-14.
Related catalog listings
Related research
Longevity
Sermorelin vs CJC-1295: the four residue substitutions that decide your half-life in published research
Same receptor, same 29-residue length, and a four-substitution structural difference that does almost all the work in published stability research. This is the comparison where "almost identical" actually means measurable.
8 min read
Longevity
Thymosin Alpha-1: Research overview, identity, and laboratory handling guide
Acetylated 28-residue thymic peptide studied in vitro for immune-cell signaling and cytokine-pathway research. ≥99% HPLC. Research use only. This guide covers identity, published research context, procurement checks, and storage — RUO only, no clinical claims.
8 min read
Longevity
Sermorelin: Research overview, identity, and laboratory handling guide
Synthetic 29-residue GHRH(1-29) analogue widely studied in vitro for GHRH-receptor binding research. ≥99% HPLC. Research use only. This guide covers identity, published research context, procurement checks, and storage — RUO only, no clinical claims.
8 min read